Key terms

About ATXI

Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in Bay Harbor Islands, FL.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ATXI news

Apr 03 7:05am ET Avenue Therapeutics’ AJ201: A Buy Rating for Innovative SBMA Treatment and Promising Clinical Progress by TipRanks Mar 20 2:01am ET Navigating the Maze: Avenue Therapeutics Grapples with Regulatory Hurdles for IV Tramadol by TipRanks Mar 15 8:23am ET Avenue Therapeutics granted extension for Nasdaq compliance by TipRanks Mar 11 8:26am ET Avenue Therapeutics to presents BAER-101 preclinical data at ASENT meeting by TipRanks Feb 24 10:01am ET Avenue Therapeutics Shareholders Approve Stock Capacity Hike by TipRanks Feb 22 8:43am ET Avenue Therapeutics announces publication of preclinical data of BAER-101 by TipRanks Feb 01 7:37am ET Buy Rating Affirmed for Avenue Therapeutics Amid Strong Prospects for IV Tramadol and Strategic Growth Potential by TipRanks Jan 24 4:18pm ET Avenue Therapeutics files to sell 33.08M shares of common stock for holders by TipRanks Jan 05 9:18am ET Avenue Therapeutics enters warrant exercise transactions for $5M in procceeds by TipRanks Jan 04 8:33am ET Avenue Therapeutics reaches final agreement with FDA for Phase 3 safety study by TipRanks Jan 03 12:20pm ET Analysts Conflicted on These Healthcare Names: Avenue Therapeutics (ATXI) and Inovio Pharmaceuticals (INO) by TipRanks

No recent press releases are available for ATXI

ATXI Financials

1-year income & revenue

Key terms

ATXI Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ATXI Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days
Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.
Patrick Reddy/The Enquirer/AP/File
Private equity finds its next bet: college admissions
In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming
Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching